ConductScience.org, home

Paper837500

Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.

Reimer KA and 2 others. Circulation, 1977. Cited by 261 papers, by iCite.

Cite this record

ConductScience Library. Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. Papers, record 837500. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/837500

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.
PubMed
Journal
Circulation
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
261
iCite
Relative citation ratio, by iCite
11.5
iCite
Revised in PubMed
2019-06-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reimer KAK A
2Lowe JEJ E
3Jennings RBR B

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalciumMajor topic
Coronary DiseaseMajor topic
VerapamilMajor topic
Animals
Dogs
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Electrocardiography
Hemodynamics
Myocardium
Necrosis

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 261 citations.

PMIDTitleJournalYearIn PapersSource
15226834Verapamil-potassium cardioplegia: a two-year experience with 470 patients.Tex Heart Inst J1986https://conductscience.org/library/papers/15226834PubMed
15216199Calcium antagonists: A new class of therapeutic agents.Cardiovasc Dis1981https://conductscience.org/library/papers/15216199PubMed
7841090How do calcium antagonists differ in clinical practice?Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7841090PubMed
6934538Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6934538PubMed
6743921Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.Br J Pharmacol1984https://conductscience.org/library/papers/6743921PubMed
6136527Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium.J Clin Invest1983https://conductscience.org/library/papers/6136527PubMed
6131809Calcium antagonists. Pharmacodynamic effects and mechanism of action.Drugs1983https://conductscience.org/library/papers/6131809PubMed
6121935Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.Klin Wochenschr1982https://conductscience.org/library/papers/6121935PubMed
6112981Calcium antagonists: definition and mode of action.Basic Res Cardiol1981https://conductscience.org/library/papers/6112981PubMed
4027150Nicardipine in models of myocardial infarction.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4027150PubMed
3985927Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs.Basic Res Cardiol1985https://conductscience.org/library/papers/3985927PubMed
3889321Are calcium antagonists cardioprotective?J R Coll Physicians Lond1985https://conductscience.org/library/papers/3889321PubMed
3530301The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3530301PubMed
3154915Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154915PubMed
3154673
Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154673PubMed
2504141Myocardial infarction in rats: effects of metabolic and pharmacologic interventions.Basic Res Cardiol1989https://conductscience.org/library/papers/2504141PubMed
2241769Determinants of infarct size in non-human primates.Basic Res Cardiol1990https://conductscience.org/library/papers/2241769PubMed
2167735Pharmacological analysis of established ventricular fibrillation.Br J Pharmacol1990https://conductscience.org/library/papers/2167735PubMed
1764340Evaluation of the protective effect of verapamil on reperfusion injury by 111In anticardiac myosin antibody in canine myocardial infarction.Ann Nucl Med1991https://conductscience.org/library/papers/1764340PubMed
1718690Protective effects of calcium antagonists against ischaemia and reperfusion damage.Drugs1991https://conductscience.org/library/papers/1718690PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/837500

GET https://conductscience.org/api/papers/v1/837500/cited_by?page=2